Oncology Devices Global Market Report 2020-30: Covid 19 Growth and Change provides the strategists, marketers and senior management with the critical information they need to assess the global oncology devices market.
This report focuses on oncology devices market which is experiencing strong growth. The report gives a guide to the oncology devices market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.
Description: Where is the largest and fastest growing market for the oncology devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Oncology Devices market global report answers all these questions and many more. The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market.It traces the market’s historic and forecast market growth by geography.
It places the market within the context of the wider oncology devices market, and compares it with other markets. • The market characteristics section of the report defines and explains the market. • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the Covid 19 virus and forecasting its growth. • Market segmentations break down market into sub markets. • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of Covid 19 for all regions, key developed countries and major emerging markets. • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified. • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers. • The oncology devices market section of the report gives context. It compares the oncology devices market with other segments of the oncology devices market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, oncology devices indicators comparison.
Scope Markets Covered: 1) By Device Type: Brachytherapy Devices; Endoscopic Devices 2) By Therapy: Chemotherapy; Hormone Therapy; Biotherapy/Immunotherapy; Radiation Therapy 3) By End User: Hospitals; Cancer Research Institutes; Others
Companies Mentioned: Eckert & Ziegler BEBIG; Oncura Inc; GE Healthcare; Medtronic plc; Varian Medical Systems Inc
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Reasons to Purchase • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies. • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates. • Create regional and country strategies on the basis of local data and analysis. • Identify growth segments for investment. • Outperform competitors using forecast data and the drivers and trends shaping the market. • Understand customers based on the latest market research findings. • Benchmark performance against key competitors. • Utilize the relationships between key data sets for superior strategizing. • Suitable for supporting your internal and external presentations with reliable high quality data and analysis • Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Our reports have been used by over 10K customers, including:
200 pages •
By The Business Research Company
• Dec 2020
Major players in the cancer monoclonal antibodies market are Amgen, Bristol Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche Ltd, Genmab AS, GlaxoSmithKline, Johnson & Johnson, Novartis AG, Merck & Co., and Spectrum Pharmaceuticals. The global cancer monoclonal antibodies market is expected to decline from $48.36 billion...
Vulvar Cancer Disease - Global Clinical Trials Review, H2, 2020 Summary clinical trial report, “Vulvar Cancer Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Vulvar Cancer Clinical trials scenario.This report provides top line data relating to the clinical trials on Vulvar...
“BENRALIZUMAB- Emerging Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for Chronic Spontaneous Urticaria in 7 Major Markets. A detailed picture of the BENRALIZUMAB in Seven Major Markets, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan,...
“DARATUMUMAB- Emerging Insight and Market Forecast – 2030” the report provides comprehensive insights about an investigational product for AL Amyloidosis in 7 Major Markets. A detailed picture of the DARATUMUMAB in Seven Major Markets, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study...
Histone Deacetylase 1 - Pipeline Review, H2 2020 Summary Histone Deacetylase 1 (HDAC1 or EC 3.5.1.98) pipeline Target constitutes close to 38 molecules. Out of which approximately 30 molecules are developed by companies and remaining by the universities/institutes. The latest report Histone Deacetylase...
The Global Oncology Partnering 2015-2020: Deal trends, players and financials report provides an understanding and access to the oncology partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in Oncology partnering deals Financial deal terms for headline, upfront and royalty...
Pheochromocytoma - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Pheochromocytoma - Pipeline Review, H2 2020, provides an overview of the Pheochromocytoma (Oncology) pipeline landscape. Pheochromocytoma is a rare, usually non-cancerous (benign)...
The Bacon market in APAC is expected to grow from US$ 6,468.6 Mn in 2019 to US$ 9,281.1 Mn by 2027; it is estimated to grow at a CAGR of 4.6% from 2020 to 2027. Increase in consumption of animal-derived products is also bolstering the growth of the food industry.The rapid rise in population expansion, along with increased urbanization...
Oligodendroglioma - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Oligodendroglioma - Pipeline Review, H2 2020, provides an overview of the Oligodendroglioma (Oncology) pipeline landscape. Oligodendroglioma is a type of glioma (primary glial...
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.